Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Slomovitz

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|February 7, 2013
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometriumAnuja Jhingran, Lois M Ramondetta, Diane C Bodurka, et al.
Gynecologic Oncology|May 7, 2008
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneumPedro T Ramirez, Kathleen M Schmeler, Michael R Milam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
Gynecologic Oncology|March 23, 2006
Are women ready for the HPV vaccine?Brian M Slomovitz, Charlotte C Sun, Michael Frumovitz, et al.
Gynecologic Oncology|May 25, 2021
Uterine carcinosarcomas: From pathology to practiceMichael D Toboni, Erin K Crane, Jubilee Brown, et al.
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
American Journal of Obstetrics and Gynecology|August 16, 2024
Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program studyGabriel Levin, Pedro T Ramirez, Jason D Wright, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine modelMichael R Milam, Joseph Celestino, Weiguo Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2025
The new 2023 endometrial cancer FIGO staging system: balancing innovation with complexityEmilia Palmieri, Andrea Mariani, Robert Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2019
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II StudyPamela T Soliman, Shannon N Westin, David A Iglesias, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|February 7, 2013
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometriumAnuja Jhingran, Lois M Ramondetta, Diane C Bodurka, et al.
Gynecologic Oncology|May 7, 2008
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneumPedro T Ramirez, Kathleen M Schmeler, Michael R Milam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
Gynecologic Oncology|March 23, 2006
Are women ready for the HPV vaccine?Brian M Slomovitz, Charlotte C Sun, Michael Frumovitz, et al.
Gynecologic Oncology|May 25, 2021
Uterine carcinosarcomas: From pathology to practiceMichael D Toboni, Erin K Crane, Jubilee Brown, et al.
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
American Journal of Obstetrics and Gynecology|August 16, 2024
Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program studyGabriel Levin, Pedro T Ramirez, Jason D Wright, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine modelMichael R Milam, Joseph Celestino, Weiguo Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2025
The new 2023 endometrial cancer FIGO staging system: balancing innovation with complexityEmilia Palmieri, Andrea Mariani, Robert Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2019
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II StudyPamela T Soliman, Shannon N Westin, David A Iglesias, et al.
Pageof 11